Host-directed therapy in foals reduces the severity of clinical pneumonia against Rhodococcus equi intrabronchial challenge

Pneumonia caused by Rhodococcus equi, an intracellular bacterium that infects macrophages, is an important cause of disease and death in immunocompromised hosts, especially foals. No vaccine is available, and control is based on antibiotic treatment of subclinical cases, increasing the pressure for...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 204; no. 1_Supplement; pp. 92 - 92.11
Main Authors Bordin, Angela Ilha, Giguere, Steeve, Bray, Jocelyne, Berghaus, Londa, Hook, Magnus, Scott, Brenton, Johnson, Rena, Cohen, Noah
Format Journal Article
LanguageEnglish
Published 01.05.2020
Online AccessGet full text

Cover

Loading…
Abstract Pneumonia caused by Rhodococcus equi, an intracellular bacterium that infects macrophages, is an important cause of disease and death in immunocompromised hosts, especially foals. No vaccine is available, and control is based on antibiotic treatment of subclinical cases, increasing the pressure for emergence of antibiotic resistance and indicating novel control approaches are needed. TLR agonists have immunomodulatory function. Our first objective was to evaluate the ex vivo effects of treatment of neonatal foal alveolar macrophages (AMs) with a combination of TLR2 and TLR9 agonists (PUL-042). Using bronchoalveolar lavage (BAL), we collected AMs from 48 foals and determined the killing of intracellular R. equi using the ratio of CFUs at 48 hours (T48) to post-phagocytosis (T0) (i.e, T48:T0). Concentration of pro- and anti-inflammatory cytokines were measured in AM culture supernatant, BAL fluid, and serum. Compared to control, PUL-042 decreased TNF-a in BAL fluid but increased IL-6, IFN-g, and TNF-a in AMs after ex vivo infection with R. equi, suggesting that nebulization induced an immune response upon infection that is favorable for killing intracellular pathogens. We also evaluated the in vivo the efficacy of PUL-042 in reducing the severity of clinical pneumonia in foals after intrabronchial challenge with R. equi. Infected foals nebulized with PUL-042 had a shorter duration of clinical signs of pneumonia and of presence of lung abscesses when compared to foals that did not receive nebulization, consistent with our ex vivo findings. Our results show potential for enhancing neonatal immune responses against respiratory pathogens and reducing severity of clinical pneumonia following intrabronchial challenge with R. equi.
AbstractList Pneumonia caused by Rhodococcus equi, an intracellular bacterium that infects macrophages, is an important cause of disease and death in immunocompromised hosts, especially foals. No vaccine is available, and control is based on antibiotic treatment of subclinical cases, increasing the pressure for emergence of antibiotic resistance and indicating novel control approaches are needed. TLR agonists have immunomodulatory function. Our first objective was to evaluate the ex vivo effects of treatment of neonatal foal alveolar macrophages (AMs) with a combination of TLR2 and TLR9 agonists (PUL-042). Using bronchoalveolar lavage (BAL), we collected AMs from 48 foals and determined the killing of intracellular R. equi using the ratio of CFUs at 48 hours (T48) to post-phagocytosis (T0) (i.e, T48:T0). Concentration of pro- and anti-inflammatory cytokines were measured in AM culture supernatant, BAL fluid, and serum. Compared to control, PUL-042 decreased TNF-a in BAL fluid but increased IL-6, IFN-g, and TNF-a in AMs after ex vivo infection with R. equi, suggesting that nebulization induced an immune response upon infection that is favorable for killing intracellular pathogens. We also evaluated the in vivo the efficacy of PUL-042 in reducing the severity of clinical pneumonia in foals after intrabronchial challenge with R. equi. Infected foals nebulized with PUL-042 had a shorter duration of clinical signs of pneumonia and of presence of lung abscesses when compared to foals that did not receive nebulization, consistent with our ex vivo findings. Our results show potential for enhancing neonatal immune responses against respiratory pathogens and reducing severity of clinical pneumonia following intrabronchial challenge with R. equi.
Author Cohen, Noah
Giguere, Steeve
Scott, Brenton
Bordin, Angela Ilha
Berghaus, Londa
Hook, Magnus
Johnson, Rena
Bray, Jocelyne
Author_xml – sequence: 1
  givenname: Angela Ilha
  surname: Bordin
  fullname: Bordin, Angela Ilha
– sequence: 2
  givenname: Steeve
  surname: Giguere
  fullname: Giguere, Steeve
– sequence: 3
  givenname: Jocelyne
  surname: Bray
  fullname: Bray, Jocelyne
– sequence: 4
  givenname: Londa
  surname: Berghaus
  fullname: Berghaus, Londa
– sequence: 5
  givenname: Magnus
  surname: Hook
  fullname: Hook, Magnus
– sequence: 6
  givenname: Brenton
  surname: Scott
  fullname: Scott, Brenton
– sequence: 7
  givenname: Rena
  surname: Johnson
  fullname: Johnson, Rena
– sequence: 8
  givenname: Noah
  surname: Cohen
  fullname: Cohen, Noah
BookMark eNqdj81KxDAUhYOMYEd9Bu8LtN7ETkvXosxa3YdMejvNkCY1P0Lx5W1BX8DVWRy-c_j2bOe8I8YeOFY11t3jxUxTdt5WAuvqPc9z1YmK8ytW8MMBy6bBZscKRCFK3jbtDdvHeEHEBkVdsO-jj6nsTSCdqIc0UlDzAsbB4JWNEKjPmuJWQKQvCiYt4AfQ1jijlYXZUZ68MwrUWRkXE7yNvvfaa50j0Gc261gK6hS806NZCT0qa8md6Y5dD-sH3f_mLWtfXz6ej6UOPsZAg5yDmVRYJEe5uco_V7m6ys1VdkJy_vR_8geAnWq1
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.4049/jimmunol.204.Supp.92.11
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 92.11
ExternalDocumentID 10_4049_jimmunol_204_Supp_92_11
GroupedDBID ---
-~X
.55
18M
2WC
34G
39C
53G
5GY
5RE
5VS
5WD
79B
85S
AARDX
AAYXX
ABCQX
ABEJV
ABJNI
ABOCM
ABPPZ
ACGFO
ACGFS
ACIWK
ACNCT
ACPRK
ADBBV
ADNWM
AENEX
AFHIN
AFOSN
AFRAH
AHWXS
AIZAD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CITATION
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
IH2
K-O
KQ8
L7B
OCZFY
OK1
P0W
P2P
PQQKQ
R.V
RHF
RHI
RZQ
SJN
TR2
TWZ
W8F
WH7
WOQ
X7M
XSW
XTH
YHG
ID FETCH-crossref_primary_10_4049_jimmunol_204_Supp_92_113
ISSN 0022-1767
IngestDate Fri Dec 06 06:11:51 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1_Supplement
Language English
LinkModel OpenURL
MergedId FETCHMERGED-crossref_primary_10_4049_jimmunol_204_Supp_92_113
ParticipantIDs crossref_primary_10_4049_jimmunol_204_Supp_92_11
PublicationCentury 2000
PublicationDate 2020-05-01
PublicationDateYYYYMMDD 2020-05-01
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-01
  day: 01
PublicationDecade 2020
PublicationTitle The Journal of immunology (1950)
PublicationYear 2020
SSID ssj0006024
Score 4.749012
Snippet Pneumonia caused by Rhodococcus equi, an intracellular bacterium that infects macrophages, is an important cause of disease and death in immunocompromised...
SourceID crossref
SourceType Aggregation Database
StartPage 92
Title Host-directed therapy in foals reduces the severity of clinical pneumonia against Rhodococcus equi intrabronchial challenge
Volume 204
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb5tAEF1ZiRr1UqVOqrZJqz20J8sUkwXMsd92K_dQuZJvCLaDbQmBiyGSk3_aX5MZdsFrK1XrXhACMVqYp5nZYeYNY6_EIIgSAbLvxx5lqzy3Hwg0hsFPOxKJDTCwqcF58s0b_RBfZu6s0_ltVC1VZWzJm3v7Sv5Hq3gN9UpdsgdothWKF_Ac9YtH1DAe_0nHo3xd9pVTgroOkggCKIOR5MSKXBAtK1E4IBTQAUKhyy_abshVBhUulvqy5tESA8Xe9wVuU9FGymrdg1_Vkugkiigu8oxqolPqE1azV8ygdttephgoqOVEUTu9rn-g2Ua64R1udhvagjmkUW-cLlrP8Hk5r0AnxUuAa_OPv5qsjN423RiVAFDMF1FVY5EGk0RmEsOxtyWDRlPBwFeTOSzQttjFna1ne6axdtSw4gaVYT37dFskpKywmq6n_XngWMqc7zsLgZsjchb6q1go2iJxVvvELj33nttsixlxG0WiwkZQiILqdYWBE1Lb-TGRNNJchw_jr22U4NmOaJjs6cVV7SEJevOHFRmRkxECTU_ZI61i_lYB8THrQNZlD9Q0002XnUx0ncYZu91BJtfI5MuM18jkGpl0gzfI5HnCG2TyFplcI5MbyOSETL6LTN4i85z5nz5O34_6zWuEK8WoEv7lE149YUdZnsFTxiEQngsYFsdSCoBg6EtHJm4gHYCh9OEZsw-V_vzwRy7Ywy2KL9lRWVTwAoPTMn5Za_kOFZyfeQ
link.rule.ids 314,780,784,27924,27925
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Host-directed+therapy+in+foals+reduces+the+severity+of+clinical+pneumonia+against+Rhodococcus+equi+intrabronchial+challenge&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Bordin%2C+Angela+Ilha&rft.au=Giguere%2C+Steeve&rft.au=Bray%2C+Jocelyne&rft.au=Berghaus%2C+Londa&rft.date=2020-05-01&rft.issn=0022-1767&rft.eissn=1550-6606&rft.volume=204&rft.issue=1_Supplement&rft.spage=92&rft.epage=92.11&rft_id=info:doi/10.4049%2Fjimmunol.204.Supp.92.11&rft.externalDBID=n%2Fa&rft.externalDocID=10_4049_jimmunol_204_Supp_92_11
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon